Cargando…
Synthesis and preclinical evaluation of [(11)C]MTP38 as a novel PET ligand for phosphodiesterase 7 in the brain
PURPOSE: Phosphodiesterase (PDE) 7 is a potential therapeutic target for neurological and inflammatory diseases, although in vivo visualization of PDE7 has not been successful. In this study, we aimed to develop [(11)C]MTP38 as a novel positron emission tomography (PET) ligand for PDE7. METHODS: [(1...
Autores principales: | Obokata, Naoyuki, Seki, Chie, Hirata, Takeshi, Maeda, Jun, Ishii, Hideki, Nagai, Yuji, Matsumura, Takehiko, Takakuwa, Misae, Fukuda, Hajime, Minamimoto, Takafumi, Kawamura, Kazunori, Zhang, Ming-Rong, Nakajima, Tatsuo, Saijo, Takeaki, Higuchi, Makoto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426238/ https://www.ncbi.nlm.nih.gov/pubmed/33674894 http://dx.doi.org/10.1007/s00259-021-05269-4 |
Ejemplares similares
-
A first-in-human study of (11)C-MTP38, a novel PET ligand for phosphodiesterase 7
por: Kubota, Manabu, et al.
Publicado: (2021) -
Imaging extra-striatal dopamine D2 receptors in a maternal immune activation rat model
por: Oh-Nishi, Arata, et al.
Publicado: (2022) -
Positron Emission Tomography Assessments of Phosphodiesterase 10A in Patients With Schizophrenia
por: Kubota, Manabu, et al.
Publicado: (2022) -
Quantification of monoacylglycerol lipase and its occupancy by an exogenous ligand in rhesus monkey brains using [(18)F]T-401 and PET
por: Hattori, Yasushi, et al.
Publicado: (2021) -
Development of TASP0410457 (TASP457), a novel dihydroquinolinone derivative as a PET radioligand for central histamine H(3) receptors
por: Koga, Kazumi, et al.
Publicado: (2016)